ClinicaliQ Trial Snapshot
- A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis — Recruiting • Phase II • Rheumatology • NCT07276581.
- AZD1163 was tested in moderate-to-severe rheumatoid arthritis patients to assess whether it works and is safe.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163. Conditions: Rheumatoid Arthritis Interventions: AZD1163, Placebo Lead Sponsor: AstraZeneca Planned Enrollment: 320 participants